Bio-View Balance Sheet Health
Financial Health criteria checks 6/6
Bio-View has a total shareholder equity of ₪27.3M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪42.0M and ₪14.7M respectively. Bio-View's EBIT is ₪137.0K making its interest coverage ratio -1. It has cash and short-term investments of ₪17.1M.
Key information
0%
Debt to equity ratio
₪0
Debt
Interest coverage ratio | -1x |
Cash | ₪17.11m |
Equity | ₪27.31m |
Total liabilities | ₪14.65m |
Total assets | ₪41.96m |
Recent financial health updates
Recent updates
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation
Dec 04Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)
Feb 14Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Jan 20What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You
Nov 29Financial Position Analysis
Short Term Liabilities: BIOV's short term assets (₪31.9M) exceed its short term liabilities (₪11.9M).
Long Term Liabilities: BIOV's short term assets (₪31.9M) exceed its long term liabilities (₪2.7M).
Debt to Equity History and Analysis
Debt Level: BIOV is debt free.
Reducing Debt: BIOV had no debt 5 years ago.
Debt Coverage: BIOV has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BIOV has no debt, therefore coverage of interest payments is not a concern.